[A new future for beta blockers: metoprolol reduces mortality and the need for heart transplantation in patients with dilated cardiomyopathy]

[Article in Italian]

No authors listed

Clinical Trial

[Article in Italian]

No authors listed. Minerva Cardioangiol. 1992 Dec.

. 1992 Dec;40(12):IX-X.

No abstract available

Similar articles

Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra G, Parolini M; SPIC (Italian Multicenter Cardiomyopathy Study) Group. De Maria R, et al. Ital Heart J. 2001 Feb;2(2):130-8. Ital Heart J. 2001. PMID: 11256541
Metoprolol in patients with dilated cardiomyopathy.
Elkayam U. Elkayam U. Circulation. 1990 Jun;81(6):2028-9. Circulation. 1990. PMID: 2344691 No abstract available.
3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.
[No authors listed] [No authors listed] Lancet. 1998 Apr 18;351(9110):1180-1. Lancet. 1998. PMID: 9643698 Clinical Trial. No abstract available.
[Adrenergic beta receptor blockaders in congestive heart failure: potential mechanisms of their action].
Ruth-Maurin A, Bilińska ZT. Ruth-Maurin A, et al. Kardiol Pol. 1988;31(6):391-401. Kardiol Pol. 1988. PMID: 2853243 Review. Polish. No abstract available.
[Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
Lohmann FW. Lohmann FW. Herz. 1990 Jun;15(3):202-6. Herz. 1990. PMID: 1973915 Review. German.